Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients [NA]
The trial has completed and evaluated circulating tumor DNA analysis at initial diagnosis to guide management in patients with advanced non-…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors [Phase 1]
Phase I trial update of Tolododekin Alfa (ANK-101) in advanced solid tumors. The study is currently recruiting.
-
CLINICAL_TRIALS other · 2026-03-06Clinical Trial Update: TOP 2301: Neoadjuvant Chemo for NSCLC [Phase 2]
A Phase 2 trial TOP 2301 evaluating neoadjuvant chemotherapy for non-small cell lung cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 2]
Phase 2 study evaluating JYP0015 in advanced solid tumors with RAS mutations is currently recruiting, including pancreatic ductal adenocarci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating difluoromethylornithine (DFMO) as an immunotherapeutic target in STK11-deficient non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations [Phase 2]
Phase 2 trial evaluating the efficacy and safety of osimertinib given before chemoradiation and as maintenance therapy in patients with Stag…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Stereotactic Radiotherapy (SBRT) of Lung Metastasis [Phase 2]
A Phase 2 clinical trial is evaluating stereotactic body radiotherapy (SBRT) for treating lung metastases in patients with non-small cell lu…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care [NA]
This clinical trial update notes an ongoing randomized study comparing molecular tumor board–assisted care to usual care for non-small cell …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the efficacy and safety of multiple therapies in cohorts of participants wit…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 adjuvant trial evaluating SMS001 (paclitaxel) for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing pralsetinib to standard of care as first-line therapy for advanced RET-fusion non-small cell lung cancer was termina…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC [Phase 2]
A Phase 2 study evaluating BL-M07D1 in combination with pembrolizumab for unresectable locally advanced or metastatic HER2-overexpressing no…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update evaluating Minnelide in combination with Osimertinib for advanced EGFR-mutated non-small cell lung cancer; the…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) [Phase 2]
A phase 2 exploratory trial studying the combination of atezolizumab and bevacizumab in hepatocellular carcinoma and metastatic non-small ce…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC [Phase 1]
This document describes a Phase Ib trial of RC148 as a monotherapy or in combination for locally advanced or metastatic non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway [Phase 1]
Phase 1 trial of DCC-3084 for MAPK-pathway driven advanced cancers has been terminated. The update notes the study status without presenting…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
A clinical trial update describes a PD-L1–targeting peptide probe for PET imaging of solid tumors, with not-yet-recruiting status and condit…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy [NA]
This clinical trial update indicates ongoing recruitment for a study evaluating practical geriatric assessment in older adults with non-smal…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update for U3-1402 in patients with metastatic or unresectable non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer [Phase 1]
Phase 1 trial evaluating ipilimumab and nivolumab in combination with radiation therapy for stage II-III non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1 [NA]
An early feasibility study of the CAROL treatment for stage 1 non-small cell lung cancer is currently recruiting, sponsored by Tau Medical A…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC [NA]
Clinical trial update indicating an exploratory study of QL1706 plus chemotherapy in perioperative non-small cell lung cancer, currently rec…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Phase II Trial of Lung Chemoemobolization [Phase 2]
Phase II trial of lung chemoembolization is currently recruiting. The listed indications include non-small cell lung cancer, mediastinal and…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the combination of Ceralasertib and Durvalumab in adults with advanced or me…